1.82
+0.0306(+1.71%)
Currency In USD
| Previous Close | 1.79 |
| Open | 1.83 |
| Day High | 1.84 |
| Day Low | 1.81 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.03 |
| Volume | 15,466 |
| Average Volume | 372,375 |
| Market Cap | 13.66M |
| PE | -1.57 |
| EPS | -1.16 |
| Moving Average 50 Days | 1.72 |
| Moving Average 200 Days | 1.7 |
| Change | 0.03 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.06 as of May 09, 2025 at a share price of $1.821. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $4,551.5 as of May 09, 2025 at a share price of $1.821.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
GlobeNewswire Inc.
10 hours ago
MELVILLE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today ann
BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025
GlobeNewswire Inc.
May 07, 2025 1:15 PM GMT
MELVILLE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is please
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
GlobeNewswire Inc.
Apr 15, 2025 12:30 PM GMT
MELVILLE, N.Y., April 15, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is plea